GSK India Narrows Focus, May Take Foot Off Pedal In CNS
Executive Summary
GlaxoSmithKline has identified five core therapy areas including dermatology, gastrointestinals and the respiratory segment for a focused effort to accelerate growth on the competitive Indian market. Segments like central nervous system (CNS) and the government institutional business could potentially be defocused.